Dr. Kanner serves as Chief Scientific Officer at Caribou Biosciences where he is leading preclinical discovery, technical operations, and translational development of genome-edited cell therapies.

Dr. Kanner serves as Chief Scientific Officer at Caribou Biosciences where he is leading preclinical discovery, technical operations, and translational development of genome-edited cell therapies.

Dr. Kanner brings more than 25 years of experience in drug discovery and development and will lead Caribou’s research and development of new applications for its gene editing technology.

Dr. Asperger described adults on the spectrum, where he made the point that we can be very successful especially in technical work. Dr. Kanner’s work was limited to children and teens, but he ...

Dr. Kanner: In my clinical experience, I’ve found that people with epilepsy do better when we effectively manage comorbid depression or anxiety. We have done some studies to test these observations.

Dr. Kanner does not believe that Alfred de Musset fell in love at 4, Byron at 8, Dante at 9, Goethe at 10. He believes that they, like many another very young child, had a “crush” on someone.

THE March issue of the Bulletin of the History of Medicine contains an interesting article on contemporary folk-lore treatment of sneezing by Dr. Leo Kanner of Baltimore, who classifies the folk ...